Lassogen is harnessing the untapped power of lasso peptides as a novel modality to treat some of the world's most challenging diseases. Founded in 2019 by leading figures in biotechnology, drug development, and academia, the company is headquartered in the biotech hub of San Diego.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/13/20 | $4,500,000 | Seed |
Better Ventures First In Ventures Playground Global  Tsingyuan Ventures | undisclosed |
